SE
Seif El Hadidi
Also known as: El HADIDI
Royal College of Surgeons in Ireland, University of Hertfordshire, University College Cork, Cairo University Faculty of Pharmacy, College De La Salle - Frere - EL Daher
0000-0002-0534-3809
Employment
-
Royal College of Surgeons in Ireland Postdoctoral Clinical Researcher2024 - Present
-
Royal College of Surgeons in Ireland Postdoctoral Researcher2024 - Present
-
University of Hertfordshire Assistant Professor2022 - Present
Education
-
University College Cork PhD2015 - 2019
-
Cairo University Faculty of Pharmacy Bsc. of Clinical Pharmacy2007 - 2012
-
College De La Salle - Frere - EL Daher Baccalaureat Francais1994 - 2007
Projects & Funding
Projects & funding information is unavailable.
Publications (31)
- Magnitude of and outcome associated with inappropriate prescribing in heart failure with reduced ejection fraction: an analysis of 50 348 patients from the Swedish Heart Failure Registry Save
- Patient-reported outcomes of the different prescribing patterns in heart failure with reduced and mildly reduced ejection fraction Save
- Mapping Irish child and young people’s health datasets and national policy frameworks: a scoping review protocol with a quantitative gap-analysis framework Save
- The hidden economic burden of potentially inappropriate prescribing in HFrEF: translating clinical risk into system-level impact Save
- Effect of age on major trauma profile and characterisation: Analysis from the national major trauma audit in Ireland Save
- How to Handle Polypharmacy in Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC Save
- Pharmacy—Physiotherapy Interprofessional Education and Practice Save
- Economic impact and clinical benefits of clinical pharmacy interventions: A six-year multi-center study using an innovative medication management tool Save
- Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document Save
- Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus document Save